Napa Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-362
Closed -$299K 156
2025
Q1
$299K Sell
362
-14
-4% -$11.6K 0.17% 139
2024
Q4
$290K Sell
376
-2,672
-88% -$2.21M 0.13% 146
2024
Q3
$2.7M Buy
3,048
+2,412
+379% +$2.17M 1.28% 11
2024
Q2
$576K Buy
+636
New +$509K 0.39% 67
2024
Q1
Sell
-4,545
Closed -$2.65M 92
2023
Q4
$2.65M Buy
+4,545
New +$2.65M 1.44% 17

Other funds holding LLY

Napa Wealth Management's LLY Position: Q2 2025 in Review

Napa Wealth Management sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 362 shares — an estimated $299K sold.

Napa Wealth Management first reported a position in LLY in Q4 2023 and held it in 5 quarters. The position peaked at $2.7M in Q3 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Napa Wealth Management reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • Napa Wealth Management sold 362 Eli Lilly shares in Q2 2025, an estimated $299K.
  • Napa Wealth Management first reported a position in Eli Lilly in Q4 2023 and held it in 5 quarters.
  • Napa Wealth Management's Eli Lilly position peaked at $2.7M in Q3 2024.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Napa Wealth Management's 13F filing for Q2 2025, filed 14 Aug 2025.